Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type-II error rates (beta errors) of randomized trials in orthopaedic trauma.

H V Lochner1, M Bhandari, P Tornetta

  • 1Department of Orthopaedic Surgery, Boston Medical Center, MA 02118, USA.

The Journal of Bone and Joint Surgery. American Volume
|November 10, 2001
PubMed
Summary

Orthopaedic trauma randomized trials often have insufficient sample sizes, leading to high rates of type-II errors (failing to detect true treatment differences). Performing power and sample-size calculations before trials can reduce these errors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of colchicine on pericoronary adipose tissue attenuation by serial coronary CT angiography: A substudy of the Ekstrom trial.

American journal of preventive cardiology·2026
Same author

Preoperative very low-energy diets for obese patients undergoing intra-abdominal colorectal surgery: a retrospective cohort study (RetroPREPARE).

Techniques in coloproctology·2024
Same author

The effects of chlorhexidine, povidone-iodine and vancomycin on growth and biofilms of pathogens that cause prosthetic joint infections: an in-vitro model.

The Journal of hospital infection·2024
Same author

The effect of coronal plane angulation on patient reported outcome measures of operatively treated distal femur fractures: A multi-center prospective evaluation.

Injury·2024
Same author

Dyslipidemia and heart failure: current evidence and perspectives of use of statins.

European review for medical and pharmacological sciences·2024
Same author

COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2).

NeuroImage. Clinical·2024

Area of Science:

  • Orthopaedic Surgery
  • Clinical Trials Methodology
  • Biostatistics

Background:

  • Randomized trials are crucial for evidence-based medicine but can be compromised by small sample sizes.
  • Small sample sizes increase the risk of type-II errors (beta errors), potentially masking real treatment effects.
  • Previous studies have not sufficiently evaluated type-II error rates and statistical power in orthopaedic trauma research.

Purpose of the Study:

  • To evaluate type-II error rates and statistical power for primary outcomes in randomized fracture care trials.
  • To determine if investigators clearly identified primary and secondary outcomes in published studies.

Main Methods:

  • Systematic review of randomized trials in fracture care published between 1968 and 1999.
  • Inclusion criteria: English language, randomized trial, adult fracture patients, sufficient outcome data for power calculation.

Related Experiment Videos

  • Power calculations performed for primary and secondary outcomes; acceptable power set at >= 80%.

    • Main Results:

    • 117 studies with 19,942 patients were analyzed; 34% focused on hip fractures.
    • Mean study power was 24.65%, significantly below the 80% standard.
    • The mean type-II error rate for primary outcomes was 90.52%, indicating a high probability of missing true treatment effects.

    Conclusions:

    • Orthopaedic trauma randomized trials analyzed exhibit unacceptably high type-II error rates.
    • Investigators must conduct power and sample-size calculations before trials to ensure adequate statistical power.
    • Addressing low statistical power is essential for generating reliable evidence in fracture care research.